- Home
- CNTX vs DIT Comparison
CNTX vs DIT Comparison
Compare CNTX & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- DIT
- Stock Information
- Founded
- CNTX 2015
- DIT 1981
- Country
- CNTX United States
- DIT United States
- Employees
- CNTX N/A
- DIT N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- DIT Food Distributors
- Sector
- CNTX Health Care
- DIT Consumer Discretionary
- Exchange
- CNTX Nasdaq
- DIT Nasdaq
- Market Cap
- CNTX 77.2M
- DIT 78.7M
- IPO Year
- CNTX 2021
- DIT 1995
- Fundamental
- Price
- CNTX $0.96
- DIT $120.35
- Analyst Decision
- CNTX Strong Buy
- DIT
- Analyst Count
- CNTX 5
- DIT 0
- Target Price
- CNTX $6.70
- DIT N/A
- AVG Volume (30 Days)
- CNTX 1.1M
- DIT 296.0
- Earning Date
- CNTX 11-06-2024
- DIT 01-31-2025
- Dividend Yield
- CNTX N/A
- DIT 0.65%
- EPS Growth
- CNTX N/A
- DIT N/A
- EPS
- CNTX N/A
- DIT 5.93
- Revenue
- CNTX N/A
- DIT $2,207,795,291.00
- Revenue This Year
- CNTX N/A
- DIT N/A
- Revenue Next Year
- CNTX N/A
- DIT N/A
- P/E Ratio
- CNTX N/A
- DIT $21.26
- Revenue Growth
- CNTX N/A
- DIT 8.41
- 52 Week Low
- CNTX $0.89
- DIT $118.25
- 52 Week High
- CNTX $2.75
- DIT $205.00
- Technical
- Relative Strength Index (RSI)
- CNTX 38.22
- DIT 39.40
- Support Level
- CNTX $0.92
- DIT $125.00
- Resistance Level
- CNTX $1.05
- DIT $135.70
- Average True Range (ATR)
- CNTX 0.13
- DIT 6.32
- MACD
- CNTX 0.01
- DIT -0.77
- Stochastic Oscillator
- CNTX 17.78
- DIT 0.00
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.